The Oxford Centre for Early Cancer Detection (OxCODE) Funding Scheme aims to advance innovative Oxford-based research that can be applied to cancer earlier detection and/or prevention. OxCODE provides short-term awards that will enable the development of proof-of-concept projects, technologies, assays and platforms to a stage at which more long-term external funding can be sought. Priority was given to projects with a clear translational trajectory towards the ultimate longer-term goal of improving clinical outcomes by lowering cancer risk or incidence, or through earlier detection.
After peer review by the OxCODE Operational Group and Oxford Cancer Patient and Public Involvement group, funds were allocated to the following projects:
- Dr I-Jun Lau (Oxford Translational Myeloma Centre) “Understanding the mechanisms of cancer evolution to Multiple Myeloma in patients with Monoclonal Gammopathy of Undetermined Significance”.
- Dr Dimitris Vavoulis (Department of Oncology) “Precise and affordable cancer detection for resource-restricted healthcare systems through shallow long-read whole-genome sequencing of liquid biopsies”
Congratulations to these teams and thank you to all applicants for their submissions.